Author:
Tubiana-Mathieu N,Bougnoux P,Becquart D,Chan A,Conte P-F,Majois F,Espie M,Morand M,Vaissiere N,Villanova G
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Albain K, Nag S, Calderillo-Ruiz G, Jordaan J, Llombart A, Pluzanska A, Rolski J, Melemed A, Reyes-Vidal J, Sekhon J, Simms L, O’Shaughnessy J (2008) Gemcitabine plus paclitaxel vs paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. J Clin Oncol 26: 3950–3957
2. Anton A, Lluch A, Casado A, Provencio M, Munoz M, Lao J, Bermejo B, Paules A, Gayo J, Martin M (2008) Phase I-II study of oral vinorelbine and capecitabine in metastatic breast cancer: results of the phase I trial. J Clin Oncol 26: 67s (abstract 1105)
3. Coates A, Stockler M, Wilcken N (2003) Controversies in Metastatic Breast Cancer: Optimal Duration of Chemotherapy. ASCO Educational Book. pp 119–121
4. Delcambre C, Veyret C, Levy C, Switsers O, Allouache D, Raban N, Grellard JM, Leconte A, Delozier T (2005) A phase I/II study of capecitabine combined with oral vinorelbine as first or second line therapy in locally advanced or metastatic breast cancer. Breast Cancer Res Treat 94: S67 (abstract 1061)
5. Ershler W (2006) Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer. Oncologist 11: 325–335
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献